| Mon 23 Oct 2023, 15:50 | | ASPEN PHARMACARE HOLDINGS LIMITED - Vesting of Securities for Directors, Company Secretary and Prescribed Officers of the Company |
|
Vesting of Securities for Directors, Company Secretary and Prescribed Officers of the Company
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
("Aspen" or "the Company")
VESTING OF SECURITIES FOR DIRECTORS, COMPANY SECRETARY AND PRESCRIBED OFFICERS OF
THE COMPANY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, disclosure is
made of the following information:
Deferred bonus shares, awarded in 2020 in respect of the Aspen South African Management Deferred
Incentive Scheme, have vested and have been delivered to the undermentioned directors, company
secretary, and prescribed officers of the Company.
Director : Stephen Bradley Saad
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 20 October 2023
Shares to be delivered – off market : 35 862
Price on acceptance : R 164.01
Value of shares to be delivered : R 5 881 726.62
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Director : Sean Matthew Capazorio
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 20 October 2023
Shares to be delivered – off market : 17 507
Price on acceptance : R 164.01
Value of shares to be delivered : R 2 871 323.07
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Name : Michael Guy Attridge – Prescribed Officer
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 20 October 2023
Shares to be delivered – off market : 29 647
Price on acceptance : R 164.01
Value of shares to be delivered : R 4 862 404.47
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Name : Reginald Haman – Prescribed Officer & Company Secretary
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 20 October 2023
Shares to be delivered – off market : 15 442
Price on acceptance : R 164.01
Value of shares to be delivered : R 2 532 642.42
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Name : Lorraine Angela Hill – Prescribed Officer
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 20 October 2023
Shares to be delivered – off market : 25 141
Price on acceptance : R 164.01
Value of shares to be delivered : R 4 123 375.41
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Name : Zizipho Mmango – Prescribed Officer
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 20 October 2023
Shares to be delivered – off market : 2 681
Price on acceptance : R164.01
Value of shares to be delivered : R 439 710.81
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Durban
23 October 2023
Sponsor
Investec Bank Limited
Date: 23-10-2023 03:50:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.